Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
wang i, hopper i (2014) celiac disease and drug absorption: implications for cardiovascular therapeutics. cardiovas ther 32: 253-256. |
|
rahul j (2015) significance of angiogenesis in both survival and extermination (via treatment) of the tumour. j pharm nanotechnol. |
|
syama s, gayathri v, mohanan pv (2015) assessment of immunotoxicity of dextran coated ferrite nanoparticles in albino mice. mol biol int 2015. |
|
shyma ms, ansar eb, gayathri v, varma hk, mohanan pv (2015) attenuation of cisplatin induced toxicity by melatonin, loaded on a dextran modified iron oxide nanoparticles: an in vitro study. dspace repository. |
|
mohana pv (2014) biocompatibility and immunotoxicity evaluation of medical devices. exp rev immunol vaccine informat 1: 4-13. |
|
tuli hs, kashyap d, sharma ak, sandhu ss (2015) molecular aspects of melatonin (mlt)-mediated therapeutic effects. life sci 135: 147-157. |
|
muro y, sugiura k, akiyama m (2015) what are the “true” pathogenic anti-desmoglein antibodies?. acta dermato-venereologica 95: 872-874. |
|
bizzaro n, tonutti e, tampoia m, infantino m, cucchiaro f, et al. (2015) specific chemoluminescence and immunoasdorption tests for anti-dfs70 antibodies avoid false positive results by indirect immunofluorescence. clin chim acta 451: 271-277. |
|
cipriani f, ricci g, leoni mc, capra l, baviera g, et al. (2014) autoimmunity in atopic dermatitis: biomarker or simply epiphenomenon?. the j dermatol 41: 569-576. |
|
rahul j (2015) significance of angiogenesis in both survival and extermination (via treatment) of the tumour. j pharm nanotechnol. |
|
ivarsen a, hjortdal j (2015) decision-making in keratoplasty. incorneal transplantation 203-217. |
|
jabbehdari s, baradaran-rafii a, yazdanpanah g, hamrah p, holland ej, et al. (2017) update on the management of high-risk penetrating keratoplasty. curr ophthalmol rep 1: 1. |
|
maharana pk, pattebahadur r, sharma n (2016) penetrating and endothelial keratoplasty: an overview. inmastering endothelial keratoplasty 29-56. |
|
baydoun l, livny e, ham l, bruinsma m, melles gr (2016) 360-degree scheimpflug imaging to predict allograft rejection after descemet membrane endothelial keratoplasty. cornea 35: 1385-1390. |
|
abud tb, di zazzo a, kheirkhah a, dana r (2017) systemic immunomodulatory strategies in high-risk corneal transplantation. j ophthal vision res 12: 81. |
|
yu t, rajendran v, griffith m, forrester jv, kuffová l, et al. (2015) high-risk corneal allografts: a therapeutic challenge. world j transplant |
|
di zazzo a, kheirkhah a, abud tb, goyal s, dana r (2016) management of high-risk corneal transplantation. survey of ophthalmol. |
|
hodge cb (2014) keratoconus in the australian population: characteristics, diagnosis and treatment. |
|
mashaghi a, marmalidou a, tehrani m, grace pm, pothoulakis c, et al. (2016) neuropeptide substance p and the immune response. cell mol life sci 73: 4249-4264. |
|
khan ma, hsu jl, assiri am, broering dc (2016) targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. clin exp immunol 183: 175-186. |
|